Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001062993-23-016036

Pres. Diagnostics & Genom gave up 4,139 shares (to pay taxes)

  • Pres. Diagnostics & Genom acquired 8,060 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kelderman Kim Pres. Diagnostics & Genom 2023-08-05 Option exercise +8,060 23,264 D
Kelderman Kim Pres. Diagnostics & Genom 2023-08-05 Shares withheld for taxes −4,139 $82.17 $340,102 19,125 D
Derivatives
Kelderman Kim Pres. Diagnostics & Genom 2023-08-05 Option exercise · Restricted Stock Units −8,060 0 D
Loading xslF345X05/form4.xml…